HGH vs PPS

ASX Financial Services sector comparison — updated 14 Jul 2026 — Financial Services sector

HGH

HEARTLAND FPO NZX [HGH]

51MEDIUM

PPS

PRAEMIUM FPO [PPS]

53MEDIUM

Score Breakdown

HGH PPS
Technical
73
41
Catalyst
51
50
Sentiment
50
50
Fundamental
94
100
Momentum
73
50
Risk Gate
42
50

Key Metrics

HGH Metric PPS
$1.0BMarket Cap$351.0M
5KAvg Volume (20d)1.4M
N/AShort Interest+0.1%
$1.11052-Week High$0.945
$0.72552-Week Low$0.620
+0.5%Daily Change+0.0%
$1.010Reference Price$0.720
+6.7%ROE+15.7%
+27.2%Profit Margin+16.2%

Active Signals

HGH Signals

Bollinger squeeze with volume pouring in — this is the kind of setup that often precedes a big move
Trading above both moving averages — the trend is your friend here
Volume surging at 33.2x normal while price climbs — real buying conviction behind this move
Watch out — volume is flowing out even as price holds up. Distribution pattern
Knocking on the door of resistance — if it punches through, things could get interesting
Volume-price trend suggests distribution — sellers may be sneaking out while price holds
Trading above the 200-day average — the long-term trend is on your side
Cash positive / operating cashflow positive

PPS Signals

Stochastic is stretched into overbought — could need a breather
Trading above both moving averages — the trend is your friend here
Volume-price trend suggests distribution — sellers may be sneaking out while price holds
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (3.2x)
Moderate revenue growth (+11%)
Piotroski F-Score strong (9/9, low-confidence approx)

Ask Scout AI to compare HGH and PPS in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

HGH vs RMC →HGH vs WTL →HLI vs JDO →HLI vs KSL →HLI vs NGI →
HGH Full Analysis → PPS Full Analysis → Financial Services Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).